The polysaccharides from fermented Ganoderma lucidum mycelia induced miRNAs regulation in suppressed HepG2 cells

Carbohydrate Polymers

Volumn 103, Issue 1, 2014, Pages 319-324

  Shen, Jie ^a   Park, Hyeon Soo ^b   Xia, Yong Mei ^a,c   Kim, Gon Sup ^b   Cui, Steve W ^c  

^a JIANGNAN UNIVERSITY   (China)

^b Gyeongsang National University   (South Korea)

^c AGRICULTURE AND AGRI FOOD CANADA   (Canada)

Author keywords

Antitumor; Ganoderma lucidum; Hepatocarcinoma; Immune; miRNA; Polysaccharide

Indexed keywords

ANTI-TUMORS; GANODERMA LUCIDUM; HEPATOCARCINOMA; IMMUNE; MIRNA;

CELLS; CYTOLOGY; DRUG PRODUCTS; POLYSACCHARIDES;

RNA;

MICRORNA; POLYSACCHARIDE;

ANTITUMOR; ARTICLE; CHEMISTRY; FERMENTATION; GANODERMA LUCIDUM; GENETICS; HEPG2 CELL LINE; HUMAN; IMMUNE; LIVER CELL CARCINOMA; METABOLISM;

ANTITUMOR; GANODERMA LUCIDUM; HEPATOCARCINOMA; IMMUNE; MIRNA; POLYSACCHARIDE;

FERMENTATION; HEP G2 CELLS; HUMANS; MICRORNAS; POLYSACCHARIDES; REISHI;

EID: 84892148938     PISSN: 01448617     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.carbpol.2013.12.044     Document Type: Article

References (38)

1. R.T. AAi, S.Y. Wu, X.Y. Wen, W. Xu, L. Lv, and S.G. Wu A new natural polyphenol BJA32531 inhibited the proliferation and regulated miRNA expression in human HepG2 hepatocarcinoma cells Journal of Chinese medicinal materials 34 11 2011 1734 1740
2. S. Bala, M. Marcos, K. Kodys, T. Csak, D. Catalano, and P. Mandrekar et al. Up-regulation of MicroRNA-155 in macrophages contributes to increased tumor necrosis factor alpha (TNF alpha) production via increased mRNA half-life in alcoholic liver disease Journal of Biological Chemistry 286 2 2011 1436 1444
3. G. Dalmasso, N. Hang Thi Thu, Y. Yan, H. Laroui, M.A. Charania, and T.S. Obertone et al. MicroRNA-92b regulates expression of the oligopeptide transporter PepT1 in intestinal epithelial cells American Journal of Physiology-Gastrointestinal and Liver Physiology 300 1 2011 G52 G59
4. M. Furuta, K.I. Kozaki, S. Tanaka, S. Arii, I. Imoto, and J. Inazawa miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma Carcinogenesis 31 5 2010 766 776
5. S.H. Hsu, B. Wang, J. Kota, J.H. Yu, S. Costinean, and H. Kutay et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver The Journal of clinical investigation 122 8 2012 2871 2883
6. X.Q. Jia, H.Q. Cheng, X. Qian, C.X. Bian, and Z.M. Shi et al. Lentivirus-Mediated Overexpression of MicroRNA-199a Inhibits Cell Proliferation of Human Hepatocellular Carcinoma Cell Biochemistry and Biophysics 62 1 2012 237 244
7. Y.S. Jia, H. Liu, Q.S. Zhuang, S.Q. Xu, and Z. Yang et al. Tumorigenicity of cancer stem-like cells derived from hepatocarcinoma is regulated by microRNA-145 Oncology reports 27 6 2012 1865 1872
8. P. Jian, Z.W. Li, T.Y. Fang, W. Jian, Z. Zhuan, and L.X. Mei et al. Retinoic acid induces HL-60 cell differentiation via the upregulation of miR-663 Journal of Hematology and Oncology 4 2011 20
9. H.F. Juan, J.W. Hsu, H.C. Huang, S.T. Chen, and C.H. Wong Ganoderma lucidum polysaccharides induce macrophage-Like differentiation in human leukemia THP-1 cells via caspase and p53 activation Evidence-Based Complementary and Alternative Medicine 2011 1 13
10. A. Karakatsanis, I. Papaconstantinou, M. Gazouli, A. Lyberopoulou, G. Polymeneas, and D. Voros Expression of microRNAs, miR-21, miR-31, miR-122, miR-145, miR-146a, miR-200c, miR-221, miR-222, and miR-223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance Molecular Carcinogenesis 52 4 2013 297 303
11. C.G. Lee, Y.W. Kim, E.H. Kim, Z. Meng, W. Huang, S.J. Hwang, and S.G. Kim Farnesoid X receptor protects hepatocytes from injury by repressing miR-199a-3p, which increases levels of LKB1 Gastroenterology 142 5 2012 1206 1217
12. C. Li, J.F. Li, Q. Cai, Q.Q. Qiu, M. Yan, and B.Y. Liu et al. MiRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer Annals of Surgical Oncology 2012
13. Y.J. Liu, J. Shen, Y.M. Xia, J. Zhang, and H.S. Park The polysaccharides from Ganoderma lucidum: Are they always inhibitors on human hepatocarcinoma cells? Carbohydrate Polymers 90 3 2012 1210 1215
14. A.I. Malik, A. Williams, C.L. Lemieux, P.A. White, and C.L. Yauk Hepatic mRNA, microRNA, and miR-34a-target responses in mice after 28 days exposure to doses of benzo(a)pyrene that elicit DNA damage and mutation Environmental and Molecular Mutagenesis 53 1 2012 10 21
15. M. Monzo, A. Navarro, E. Bandres, R. Artells, I. Moreno, and B. Gel et al. Overlapping expression of microRNAs in human embryonic colon and colorectal cancer Cell Research 18 8 2008 823 833
16. C.M. Narbus, B. Israelow, M. Sourisseau, M.L. Michta, S.E. Hopcraft, G.M. Zeiner, and M.J. Evans HepG2 Cells Expressing MicroRNA miR-122 Support the Entire Hepatitis C Virus Life Cycle Journal of Virology 85 22 2011 12087 12092
17. O.M. Niemoeller, M. Niyazi, S. Corradini, F. Zehentmayr, M. Li, and K. Lauber et al. MicroRNA expression profiles in human cancer cells after ionizing radiation Radiation Oncology 6 1 2011 29
18. J. Pan, H. Hu, Z. Zhou, L. Sun, L. Peng, and L. Yu et al. Tumor-suppressive mir-663 gene induces mitotic catastrophe growth arrest in human gastric cancer cells Oncology Reports 24 1 2010 105 112
19. M. Petre, A. Teodorescu, E. Tuluca, C. Bejan, and A. Andronescu Biotechnology of mushroom pellets producing by controlled submerged fermentation Romanian Biotechnological Letters 15 2010 50 55
20. K. Sakurai, C. Furukawa, T. Haraguchi, K. Inada, K. Shiogama, and T. Tagawa et al. MicroRNAs miR-199a-5p and-3p target the Brm subunit of SWI/SNF to generate a double-negative feedback loop in a variety of human cancers Cancer Research 71 5 2011 1680 1689
21. M. Sand, M. Skrygan, D. Sand, D. Georgas, T. Gambichler, and S.A. Hahn et al. Comparative microarray analysis of microRNA expression profiles in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases, and benign melanocytic nevi Cell and Tissue Research 351 2013 85 98
22. C. Schmelzer, M. Kitano, G. Rimbach, P. Niklowitz, T. Menke, and K. Hosoe et al. Effects of ubiquinol-10 on microRNA-146a expression in vitro and in vivo Mediators of Inflammation 2009
23. S. Sengupta, J. Nie, R.J. Wagner, C. Yang, R. Stewart, and J.A. Thomson MicroRNA 92b controls the G1/S checkpoint gene p57 in human embryonic stem cells Stem Cells 27 7 2009 1524 1528
24. M. Shigoka, A. Tsuchida, T. Matsudo, Y. Nagakawa, and H. Saito et al. Deregulation of miR-92a expression is implicated in hepatocellular carcinoma development Pathology international 60 5 2010 351 357
25. S.R. Siegel, J. Mackenzie, G. Chaplin, N.G. Jablonski, and L. Griffiths Circulating microRNAs involved in multiple sclerosis Molecular Biology Reports 39 5 2012 6219 6225
26. H. Su, J.R. Yang, T. Xu, J. Huang, L. Xu, and Y. Yuan et al. MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity Cancer Research 69 3 2009 1135 1142
27. W. Wang, L.J. Zhao, Y.X. Tan, H. Ren, and Z.T. Qi Identification of deregulated miRNAs and their targets in hepatitis B virus-associated hepatocellular carcinoma World Journal of Gastroenterology 18 38 2012 5442 5453
28. B. Wang, S.H. Hsu, W. Frankel, K. Ghoshal, and S.T. Jacob Stat3-mediated activation of microRNA-23a suppresses gluconeogenesis in hepatocellular carcinoma by down-regulating glucose-6-phosphatase and peroxisome proliferator-activated receptor gamma, coactivator 1 alpha Hepatology 56 1 2012 186 197
29. Z.H. Weng, D.D. Wang, W.Y. Zhao, M.Q. Song, F.P. You, L. Yang, and L.B. Chen microRNA-450a targets DNA methyltransferase 3a in hepatocellular carcinoma Experimental and Therapeutic Medicine 2 5 2011 951 955
30. N.N. Wu, X.Y. Liu, X.M. Xu, X.X. Fan, M. Liu, X. Li, Q.P. Zhong, and H. Tang MicroRNA-373, a new regulator of protein phosphatase 6, functions as an oncogene in hepatocellular carcinoma Febs Journal 278 12 2011 2044 2054
31. Q.H. Xie, X.X. He, Y. Chang, S.Z. Sun, X. Jiang, P.Y. Li, and J.S. Lin MiR-192 inhibits nucleotide excision repair by targeting ERCC3 and ERCC4 in HepG2.2.15 cells. Biochemical and Biophysical Research Communications 410 3 2011 440 445
32. J. Xu, C. Wu, X. Che, L. Wang, D. Yu, and T.W. Zhang et al. Circulating MicroRNAs, miR-21, miR-122, and miR-223, in patients with hepatocellular carcinoma or chronic hepatitis Molecular Carcinogenesis 50 2 2011 136 142
33. M. Yang, R. Liu, J. Sheng, J. Liao, Y. Wang, and E. Pan et al. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma Oncology Reports 29 1 2013 169 176
34. Y. Zhang, J.M. Liao, S.Y.X. Zeng, and H. Lu p53 downregulates Down syndrome-associated DYRK1A through miR-1246 EMBO Reports 12 8 2011 811 817
35. S. Zheng, Y. Jia, J. Zhao, Q. Wei, and Y. Liu Ganoderma lucidum polysaccharides eradicates the blocking effect of fibrinogen on NK cytotoxicity against melanoma cells Oncology Letters 3 3 2012 613 616
36. D.X. Zhu, W. Zhu, C. Fang, L. Fan, Z.J. Zou, and Y.H. Wang et al. miR-181a/b significantly enhances drug sensitivity in chronic lymphocytic leukemia cells via targeting multiple anti-apoptosis genes Carcinogenesis 33 7 2012 1294 1301
37. L. Zhuo, J. Liu, B. Wang, M. Gao, and A. Huang Differential miRNA expression profiles in hepatocellular carcinoma cells and drug-resistant sublines Oncology Reports 29 2 2013 555 562
38. J. Zhou, and W. Wang Analysis of microRNA expression profiling identifies microRNA-503 regulates metastatic function in hepatocellular cancer cell Journal of Surgical Oncology 104 3 2011 278 283